By continuing to use our site, you consent to the processing of cookies, user data (location information, type and version of the OS, the type and version of the browser, the type of device and the resolution of its screen, the source of where the user came from, from which site or for what advertisement, language OS and Browser, which pages are opened and to which buttons the user presses, ip-address) for the purpose of site functioning, retargeting and statistical surveys and reviews. If you do not want your data to be processed, please leave the site.

Replica Analytics Joins Alberta’s Synthetic Data Project

(Ottawa, June 16, 2021) Replica Analytics announces a partnership with Health City to join an innovative Alberta collaboration with the Institute of Health Economics, Merck Canada, Alberta Innovates, and the University of Alberta.

Replica Analytics Adds Bench Strength to its Health Technology Brain Trust

(Ottawa, June 9, 2021) Replica Analytics announced today the formation of an Advisory Board and its first three members.

Replica Analytics and Euris Launch Cloud-Based Data Synthesis Platform

(Ottawa, June 2, 2021) Replica Analytics, a leading provider of health data synthesis technology, is partnering with Euris Health Cloud® bringing to market a unique and easy-to-use cloud-based data synthesis solution: Replica Synthesis.

New Partnership Between Aridhia and Replica Analytics

(Ottawa, May 26, 2021) Aridhia and Replica Analytics announced today a new partnership integrating the data synthesis solution from Replica Analytics with the Digital Research Environment (DRE) from Aridhia.

Replica Analytics Announces New Funding from Nina Capital

Replica Analytics has closed a financing round with Nina Capital. This new funding injection will enable Replica Analytics to continue developing our data synthesis technology and expand our capabilities for creating robust simulators and digital twins.

Replica Analytics Data Synthesis Platform Launched to Support Data Transparency and Data Science Globally

Replica Analytics Ltd., a leading provider of privacy protective synthetic data, is proud to announce that it is providing its data synthesis platform to PHUSE members.

FACIT backs made-in-Ontario data science and medtech innovations through Prospects Oncology Fund

Replica Analytics and Sunnybrook’s Czarnota Lab receive key seed funding to de-risk Ontario intellectual property

First Synthetic Health Dataset in Province

Project Increases Data Accessibility While Maintaining Patient Privacy

New Funding for Data Synthesis Innovations

(September 9, 2020) Replica Analytics, a leading provider of privacy protective synthetic data, is proud to announce that it received over $1 million in new pre-seed funding.